Similarly, ST6GALNAC2 participates in STn antigen generation to a lesser extent and demonstrates high expression in CRC, and exhibits advanced cancer progression in follicular thyroid carcinomas (FTC) [16,17]. Here, ST6GALNAC2 is linked to colorectal carcinoma.